(ACTU) Actuate Therapeutics - Performance -27.5% in 12m
ACTU performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-22.91%
#44 in Peer-Group
Rel. Strength
16.77%
#6406 in Stock-Universe
Total Return 12m
-27.53%
#93 in Peer-Group
Total Return 5y
-27.53%
#43 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 11.90 USD |
| 52 Week Low | 5.80 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 12.27 |
| Buy/Sell Signal +-5 | 0.62 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ACTU (-27.5%) vs XBI (-9.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.02% | 69.7% | 77.8% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-10.4% | -7.09% | 151% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.42% | -1.57% | 39.4% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.65% | 30.3% | -1.81% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.39% | -9.49% | -0.73% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
10.5% | 38.7% | -6.49% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-7.82% | 50.2% | -13.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.95% | 29.1% | 18.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ACTU vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ACTU
| Total Return (including Dividends) | ACTU | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -28.36% | 0.53% | 3.75% |
| 3 Months | -10.47% | 21.37% | 25.32% |
| 12 Months | -27.53% | -9.11% | 13.11% |
| 5 Years | -27.53% | -25.99% | 109.78% |
| Trend Score (consistency of price movement) | ACTU | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -88.8% | -5.7% | 80.3% |
| 3 Months | -27.7% | 79.4% | 97.2% |
| 12 Months | 6.9% | -86.9% | 45.4% |
| 5 Years | 6.9% | -52.2% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th3.00 | -28.74% | -30.95% |
| 3 Month | %th13.00 | -26.24% | -28.56% |
| 12 Month | %th55.00 | -17.08% | -37.45% |
| 5 Years | %th76.00 | -17.08% | -37.45% |
FAQs
Does Actuate Therapeutics (ACTU) outperform the market?
No,
over the last 12 months ACTU made -27.53%, while its related Sector, the SPDR S&P Biotech (XBI) made -9.11%.
Over the last 3 months ACTU made -10.47%, while XBI made 21.37%.
Performance Comparison ACTU vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ACTU vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.4% | -32.1% | -27.9% | -41% |
| US NASDAQ 100 | QQQ | 0.8% | -32.6% | -29.5% | -39% |
| German DAX 40 | DAX | -0.5% | -28.6% | -40.6% | -58% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.3% | -32.1% | -31.6% | -49% |
| Hongkong Hang Seng | HSI | 1.8% | -31.4% | -48.4% | -66% |
| India NIFTY 50 | INDA | 2.1% | -29.2% | -28.4% | -27% |
| Brasil Bovespa | EWZ | 2.1% | -34.2% | -49.9% | -35% |
ACTU vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.7% | -31.9% | -32.4% | -52% |
| Consumer Discretionary | XLY | 2.1% | -30.4% | -20.1% | -43% |
| Consumer Staples | XLP | 2.6% | -28.8% | -28.4% | -35% |
| Energy | XLE | -1.8% | -35.1% | -24.2% | -30% |
| Financial | XLF | 2.6% | -31.1% | -30.4% | -55% |
| Health Care | XLV | 3.1% | -29.5% | -18.9% | -23% |
| Industrial | XLI | 1.2% | -31.5% | -34.8% | -52% |
| Materials | XLB | 0.5% | -32.1% | -31.5% | -33% |
| Real Estate | XLRE | 2.5% | -28.2% | -26.8% | -39% |
| Technology | XLK | -0.3% | -35.5% | -32% | -38% |
| Utilities | XLU | 2.8% | -29.6% | -30.3% | -49% |
| Aerospace & Defense | XAR | 0.7% | -32.1% | -46.1% | -75% |
| Biotech | XBI | -0.2% | -28.9% | -13.8% | -18% |
| Homebuilder | XHB | 2.6% | -34.4% | -20% | -31% |
| Retail | XRT | 1.3% | -29.9% | -23.2% | -37% |
ACTU vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -2.3% | -35.2% | -21.6% | -23% |
| Natural Gas | UNG | 3.6% | -17.9% | -8.7% | -21% |
| Gold | GLD | 2.9% | -27.6% | -45.7% | -67% |
| Silver | SLV | 0.1% | -28.1% | -43.5% | -46% |
| Copper | CPER | -5.2% | -38.4% | -48.3% | -46% |
ACTU vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 4.2% | -29.4% | -24.2% | -24% |
| iShares High Yield Corp. Bond | HYG | 2% | -29.7% | -26.3% | -37% |